As Reported Financial Statements
As-reported financial charting

As Reported Financials

Document Name As Of Date Currency Code (in units) 2015 Y 10-K 12/31/2015 USD 2016 Y 10-K 12/31/2016 USD 2017 Y 10-K 12/31/2017 USD 2018 Y 10-K 12/31/2018 USD 2019 Q3 YTD 10-Q 9/30/2019 USD
Document Name As Of Date Currency Code 2015 Y 10-K 12/31/2015 USD 2016 Y 10-K 12/31/2016 USD 2017 Y 10-K 12/31/2017 USD 2018 Y 10-K 12/31/2018 USD 2019 Q3 YTD 10-Q 9/30/2019 USD

Cash flows from operating activities
Net income 27,020,000 31,913,000 31,274,000 42,024,000 36,139,000

Adjustments to reconcile net income to net cash from operating activities
Depreciation and amortization 11,654,000 9,576,000 10,358,000 9,766,000 6,997,000
Accretion of acquired loans (5,338,000) (4,925,000) (2,338,000) (1,373,000) (522,000)
Provision for loan losses (1,000,000) 2,900,000 2,950,000 1,100,000 2,450,000
Deferred income tax expense (benefit) 4,412,000 (812,000) 831,000 (372,000) NA
Stock-based compensation expense 684,000 1,459,000 1,981,000 2,410,000 2,199,000
Stock grants to directors for retainer fee 403,000 327,000 363,000 441,000 375,000
Proceeds from sales of mortgage loans held for sale 120,880,000 114,757,000 111,311,000 101,146,000 163,056,000
Origination of mortgage loans held for sale (116,997,000) (110,778,000) (108,857,000) (96,179,000) (169,661,000)
Net gain from sales of mortgage loans held for sale (3,626,000) (3,699,000) (3,972,000) (3,536,000) (5,032,000)
Gain on trust preferred securities repurchase 0 (2,970,000) 0 0 NA
Net gain from sales and valuation write-downs of foreclosed assets (62,000) (520,000) (319,000) (169,000) (132,000)
Net gain from sales and valuation write-downs of former bank premises 0 35,000 133,000 (78,000) (559,000)
Net loss from sales and write-downs of fixed assets 55,000 174,000 71,000 134,000 5,000
Net (gain) loss from sales of available for sale securities (17,000) 1,000 (37,000) 0 NA
Earnings on bank owned life insurance (1,113,000) (1,264,000) (2,731,000) (1,287,000) (3,567,000)
Net change in
Accrued interest receivable (321,000) 122,000 (1,056,000) (1,126,000) (609,000)
Other assets (4,815,000) (648,000) (354,000) (2,193,000) (7,163,000)
Accrued interest payable and other liabilities 4,185,000 (1,046,000) (943,000) 11,029,000 (3,843,000)
Net cash from operating activities 36,004,000 34,602,000 38,665,000 61,737,000 20,133,000

Cash flows from investing activities
Loan originations and payments, net (188,932,000) (97,282,000) (178,373,000) (193,556,000) (168,412,000)
Purchases of securities available for sale (10,645,000) (164,336,000) (67,027,000) (48,664,000) (53,353,000)
Proceeds from maturities, calls and repayments of securities available for sale 93,873,000 172,173,000 52,504,000 40,308,000 60,617,000
Proceeds from sales of securities available for sale 1,483,000 264,000 7,619,000 0 NA
Proceeds from sales of foreclosed assets 2,967,000 2,059,000 993,000 772,000 632,000
Proceeds from sales of former bank premises 0 45,000 25,000 1,964,000 854,000
Purchases of Federal Home Loan Bank stock 0 (459,000) (3,010,000) (4,986,000) (1,980,000)
Proceeds from Federal Home Loan Bank stock redemption 6,132,000 NA NA NA NA
Purchases of bank owned life insurance 0 (7,000,000) (1,500,000) 0 (2,500,000)
Proceeds from bank owned life insurance cash value release and death benefits 0 0 2,720,000 0 7,708,000
Net purchases of premises and equipment (1,081,000) (2,025,000) (5,423,000) (6,318,000) (9,109,000)
Net cash for investing activities (96,203,000) (96,561,000) (191,472,000) (210,480,000) (165,543,000)

Cash flows from financing activities
Net increase (decrease) in time deposits (147,106,000) (20,854,000) (55,839,000) (30,091,000) 196,035,000
Net increase in all other deposits 146,944,000 120,457,000 203,219,000 (28,566,000) 107,348,000
Net increase (decrease) in securities sold under agreements to repurchase (12,798,000) (23,061,000) (12,962,000) (15,229,000) 471,000
Maturities of Federal Home Loan Bank advances (6,000,000) (3,000,000) (45,000,000) (30,000,000) (30,000,000)
Proceeds from Federal Home Loan Bank advances 20,000,000 110,000,000 90,000,000 160,000,000 44,000,000
Proceeds from stock option exercises 891,000 978,000 318,000 108,000 16,000
Employee stock purchase plan 44,000 36,000 46,000 52,000 39,000
Dividend reinvestment plan 655,000 1,601,000 1,576,000 1,165,000 541,000
Repurchases of common stock shares (15,762,000) (3,732,000) 0 (5,943,000) (7,110,000)
Repurchase of trust preferred securities 0 (8,030,000) 0 0 NA
Payment of cash dividends to common shareholders (9,516,000) (18,731,000) (12,046,000) (27,500,000) (12,746,000)
Net cash from (for) financing activities (22,648,000) 155,664,000 169,312,000 23,996,000 298,594,000
Net change in cash and cash equivalents (82,847,000) 93,705,000 16,505,000 (124,747,000) 153,184,000
Cash and cash equivalents at beginning of period 172,738,000 89,891,000 183,596,000 200,101,000 75,354,000
Cash and cash equivalents at end of period 89,891,000 183,596,000 200,101,000 75,354,000 228,538,000

Supplemental disclosures of cash flows information

Cash paid during the period for
Interest 11,618,000 12,477,000 15,468,000 21,569,000 23,361,000
Federal income tax 8,000,000 15,125,000 14,225,000 10,075,000 8,875,000

Noncash financing and investing activities
Transfers from loans to foreclosed assets 2,203,000 414,000 887,000 744,000 227,000
Transfers from bank premises to other real estate owned 0 381,000 1,736,000 296,000 0
Data shown on this page is extracted directly from the company’s documents. S&P makes every effort to line up fields, captions and headers that represent the same data over time, despite variations in how the company may report these items in different documents. In certain instances the variation in the company’s presentation over time may be too significant, potentially resulting in repeating and/or disordered items. Despite possible issues with the presentation, S&P, as always, stands by its commitment to the quality of the data.